Literature DB >> 10354898

Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.

H S Thomsen1, S K Morcos.   

Abstract

The purpose of this study was to establish guidelines on how to avoid metformin-induced lactic acidosis following intravascular use of contrast media. We reviewed articles published in international journals. No conclusive evidence was found to indicate that the intravascular use of contrast media precipitated the development of metformin-induced lactic acidosis in patients with normal S-creatinine (< 130 mumol/l). The complication was almost always observed in non-insulin-dependent diabetic patients with decreased renal function before injection of contrast media. Guidelines for the use of contrast media in this group of patients are proposed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354898     DOI: 10.1007/s003300050746

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  13 in total

Review 1.  Contrast media: interactions with other drugs and clinical tests.

Authors:  Sameh K Morcos; Henrik S Thomsen; C M Exley
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

2.  Five things to know about...metformin and intravenous contrast.

Authors:  Mark Otto Baerlocher; Murray Asch; Andy Myers
Journal:  CMAJ       Date:  2012-10-09       Impact factor: 8.262

Review 3.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

4.  Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury.

Authors:  D Blair Macdonald; Casey D Hurrell; Andreu F Costa; Matthew D F McInnes; Martin O'Malley; Brendan J Barrett; Pierre Antoine Brown; Edward G Clark; Anastasia Hadjivassiliou; Iain Donald Craik Kirkpatrick; Jeremy Rempel; Paul Jeon; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2022-05-24

5.  New guidelines on the use of iodinated contrast media: a report on an implementation project.

Authors:  M G Bonetti; A Vesprini; M Concetti; S Ventrella; M F Spagna; S Mancinelli; M Santini; A Romanelli; P Pantanetti; C Cameli; L Bonanni; L Baffoni
Journal:  Radiol Med       Date:  2009-03-25       Impact factor: 3.469

6.  Update on Safety Issues Related to Antihyperglycemic Therapy.

Authors:  Gandahari Rosa A Carpio; Vivian A Fonseca
Journal:  Diabetes Spectr       Date:  2014-05

Review 7.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 8.  Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Life (Basel)       Date:  2021-04-25

9.  Post-Contrast Acute Kidney Injury in Patients with Various Stages of Chronic Kidney Disease-Is Fear Justified?

Authors:  Inga Chomicka; Marlena Kwiatkowska; Alicja Lesniak; Jolanta Malyszko
Journal:  Toxins (Basel)       Date:  2021-06-01       Impact factor: 4.546

Review 10.  Contrast-induced Nephropathy.

Authors:  Nazar M A Mohammed; Ahmed Mahfouz; Katafan Achkar; Ihsan M Rafie; Rachel Hajar
Journal:  Heart Views       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.